Respiratory News and Research

RSS

Lupin Pharmaceuticals receives FDA approval for Suprax

Lupin Pharmaceuticals has announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for Suprax (Cefixime for oral suspension 200mg/5ml).

15 Apr 2007

New device increases circulation and blood flow to vital organs during CPR

In the United States, a person's chance of surviving cardiac arrest is probably much lower than most people realize: 17-19 percent in hospitals.

15 Apr 2007

Abbott opens biotech facility in Puerto Rico

"This new facility is a key milestone for Abbott as we move to focus our resources and future growth on biologic and potent-drug manufacturing," said Lawrence Kraus, vice president of manufacturing, global pharmaceutical operations, Abbott.

11 Apr 2007

Weak immune response critical to disease that causes most infant hospitalizations

The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two.

7 Apr 2007

Smoke from other people's burning tobacco kills

The debate is over, according to a 2006 surgeon general's report on secondhand smoke.

5 Apr 2007

Mediterranean diet protects against allergic rhinitis and asthma

A "Mediterranean" diet rich in fruits, vegetables and nuts protects against allergic rhinitis and asthma symptoms, suggests research published ahead of print in Thorax.

5 Apr 2007

Andover Medical to acquire Ortho-Medical Products

A single source provider of orthopedic, podiatric and urological durable medical equipment and incontinence treatment solutions, announced today that it has entered into a definitive merger agreement to acquire Ortho-Medical Products, Inc.

5 Apr 2007

CleveMed completes first virtually attended home sleep study using mobile phone broadband internet service

Cleveland Medical Devices Inc. (CleveMed) announced that it recently conducted the first virtually attended sleep study using mobile phone broadband internet service from a subject's home.

5 Apr 2007

St. Jude Children's Research Hospital designated as Center of Excellence for Influenza Research and Surveillance

St. Jude Children's Research Hospital has been designated one of six Centers of Excellence for Influenza Research and Surveillance funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health.

4 Apr 2007

Inhaled corticosteroids deserve further consideration for lung cancer chemoprevention

Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers a greater susceptibility to lung cancer, researchers found that regular use of high dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer.

4 Apr 2007

For overweight and obese individuals, the incidence of asthma increases by 50 percent

Asthma, a respiratory disease characterized by recurrent episodes of difficult breathing, wheezing, cough and thick mucus production, affected approximately 20.5 million Americans in 2004. Some common asthma triggers are allergic stimuli, infections, stress or strenuous exercise.

4 Apr 2007

New way of making artificial lungs more efficient

Artificial lungs are cumbersome beasts, but they can be a lifesaver for people with serious respiratory diseases or lung damage. Sitting outside the body, they take over the task of soaking up excess carbon dioxide from the blood and infusing it with oxygen.

4 Apr 2007

Six centers of excellence for influenza research and surveillance established in U.S.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

2 Apr 2007

Patient safety incidents at the nation's hospitals rose three percent

Patient safety incidents at the nation's hospitals rose three percent over the years 2003 to 2005, but the nation's top-performing hospitals had a 40 percent lower rate of medical errors when compared with the poorest-performing hospitals, according to the largest annual study of patient-safety issued today by HealthGrades, the leading independent healthcare ratings company.

2 Apr 2007

GlaxoSmithKline files European meningococcal conjugate vaccine

GlaxoSmithKline has announced the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix (diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Neisseria meningitides serogroups A and C).

1 Apr 2007

Coronary procedure adds no benefit over 'optimal medical therapy' alone

Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.

1 Apr 2007